GE HealthCare Technologies Inc. $GEHC Stock Acquired by Lido Advisors LLC

Lido Advisors LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 90.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,613 shares of the company’s stock after purchasing an additional 12,157 shares during the period. Lido Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,674,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. NBH Bank purchased a new position in GE HealthCare Technologies in the second quarter valued at $26,000. Provenance Wealth Advisors LLC raised its stake in GE HealthCare Technologies by 401.0% in the third quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock valued at $32,000 after buying an additional 393 shares in the last quarter. Fortitude Family Office LLC lifted its holdings in GE HealthCare Technologies by 249.1% during the 3rd quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock worth $39,000 after buying an additional 426 shares during the last quarter. Aberdeen Wealth Management LLC purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth about $44,000. Finally, Heritage Family Offices LLP purchased a new stake in GE HealthCare Technologies during the 3rd quarter worth about $44,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Zacks Research upgraded GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. UBS Group boosted their target price on GE HealthCare Technologies from $73.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 3rd. Weiss Ratings raised GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 6th. Barclays upped their price target on GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, October 29th. Finally, Oppenheimer reiterated an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $82.17.

Check Out Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $83.02 on Monday. The company has a fifty day moving average of $70.55 and a two-hundred day moving average of $70.11. The company has a market capitalization of $37.54 billion, a PE ratio of 17.51, a P/E/G ratio of 2.09 and a beta of 0.64. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The business had revenue of $5.51 billion for the quarter, compared to analysts’ expectations of $5.35 billion. During the same quarter in the previous year, the firm earned $1.07 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. As a group, analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Friday, October 23rd were paid a dividend of $0.04 per share. The ex-dividend date was Friday, October 23rd. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.38%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.